"We are probably nearing the limit of all we can know about astronomy."
Simon Newcomb, astronomer ; 1888
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6224883 | Process and composition for therapeutic cisplatin (CDDP) An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The... | 05/01/2001 |
| 6077545 | Process and composition for therapeutic cisplatin (CDDP) An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The... | 06/20/2000 |
| 5968355 | Apparatus for aseptic vortex flow concentration An apparatus is provided having a rotor inside a membrane for the aseptic vortex flow concentration of a liquid or semisolid dispersion which has a shed-resistant bearing interface so that unwanted bearing material does not contaminate the substances, e.g... | 10/19/1999 |
| 5925246 | Apparatus for aseptic vortex flow concentration An apparatus is provided having a rotor inside a membrane for the aseptic vortex flow concentration of a liquid or semisolid dispersion which has a shed-resistant bearing interface so that unwanted bearing material does not contaminate the substances, e.g... | 07/20/1999 |
| 5874402 | Use of cell membrane permeants in the treatment of cellular proliferative diseases Methods are provided for the treatment of a host suffering from a cellular proliferative disease through administration of a chemotherapeutic agent in conjunction with a cell membrane permeant. Optionally, the cell membrane permeant and/or chemotherapeuti... | 02/23/1999 |
| 5874006 | Aseptic collagen concentration process A process for the aseptic concentration of collagen from about 0.25% (w/w) suspensions to gels of 15% using vortex flow filtration with a variety of membrane types--ultrafiltration and microfiltration and polymeric and stainless steel is provided. The res... | 02/23/1999 |